Results 31 to 40 of about 93,078 (303)

Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma. [PDF]

, 2017
BackgroundThe prevalence of cancer cachexia in veterinary medicine has not been studied widely, and as of yet, no definitive diagnostic criteria effectively assess this syndrome in veterinary patients.Objectives(1) To determine the patterns of weight ...
Boston, SE, Culp, WTN, Kilkenny, JJ, Lu, X, Singh, A, Skorupski, KA, Story, AL, Woods, JP   +7 more
core   +1 more source

Systemic inflammation, nutritional status and survival in patients with cancer [PDF]

, 2009
Systemic inflammation, nutritional status and survival in patients with ...
Al Murri, Brown, Cho, Crumley, Crumley, Crumley, Fearon, Forrest, Forrest, Gabay, Glen, Gomez, Gridelli, Halazun, Hara, Hilmy, Ishizuka, Jamieson, Karakiewicz, Kerem, Kobayashi, Krzystek-Korpacka, Leitch, Malik, Marsik, McMillan, McMillan, Morley, Ramsey, Read, Sharma, Sharma, Walsh, Yamanaka   +33 more
core   +1 more source

Potential role of immunological factors in early diagnosis of cancer cachexia in C26 tumor-bearing mice

Applied Biological Chemistry, 2019
Cachexia is a wasting syndrome associated with high mortality in cancer patients through inducing the failure of normal metabolism and reducing the efficacy of cancer treatment. Thus, it is critically important to diagnose cancer cachexia early.
Jae Eun Ju, Mi-Sook Kim, Joo Hyun Kang, Ji Young Lee, Mi So Lee, Eun Ho Kim, Namhyun Chung, Youn Kyoung Jeong   +7 more
doaj   +1 more source

Targeting cancer cachexia: Molecular mechanisms and clinical study

MedComm, 2022
Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia,
Yong‐Fei Wang, Zi‐Yi An, Dong‐Hai Lin, Wei‐Lin Jin   +3 more
doaj   +1 more source

Cancer cachexia [PDF]

British Journal of Cancer, 1991
Cachexia is a common problem in the clinical management of cancer patients, particularly those with solid tumors. Cachexia is most obviously manifested as weight loss with massive depletion of both adipose tissue and muscle mass, and death is probably due to loss of lean body tissue.
openaire   +5 more sources

Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study

OncoImmunology, 2021
Although previous studies suggest that cancer cachexia is a poor prognostic factor for immune checkpoint inhibitor monotherapy, the impact of cancer cachexia on chemoimmunotherapy is unclear.
Kenji Morimoto, Junji Uchino, Takashi Yokoi, Takashi Kijima, Yasuhiro Goto, Akira Nakao, Makoto Hibino, Takayuki Takeda, Hiroyuki Yamaguchi, Chieko Takumi, Masafumi Takeshita, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama   +18 more
doaj   +1 more source

Behavioural changes are a major contributing factor in the reduction of sarcopenia in calorie-restricted ageing mice [PDF]

, 2015
Background: In rodent models, caloric restriction (CR) with maintenance of adequate micronutrient supply has been reported to increase lifespan and to reduce age-induced muscle loss (sarcopenia) during ageing.
Anker, Argentino, Arnal, Austad, Bales, Boily, Boirie, Bool, Bouillanne, Campbell, Cano, Cava, Chen, Collins, Corhay, Cruz-Jentoft, Cuervo, Dwarkasing, Evans, Gallardo, Greenwood, Haehling, Harper, Lemon, Li, Loos, Luby, McKiernan, Michan, Miller, Mischke, Morris, Norren, Norren, Patel, Sandri, Santa Mina, Sanz, Scharf, Severinsen, Simpson, Speakman, Tieland, Walrand, Walrand   +44 more
core   +3 more sources

Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients

Journal of Cachexia, Sarcopenia and Muscle, 2018
Background Cachexia is a multifactorial syndrome that is highly prevalent in advanced cancer patients and leads to progressive functional impairments. The classification of cachexia stages is essential for diagnosing and treating cachexia. However, there
Ting Zhou, Bangyan Wang, Huiquan Liu, Kaixiang Yang, Sudip Thapa, Haowen Zhang, Lu Li, Shiying Yu   +7 more
doaj   +1 more source

One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA

Drugs in Context, 2014
Background: Cachexia is a condition characterized as a loss in body mass or metabolic dysfunction and is associated with several prevalent chronic health conditions including many cancers, COPD, HIV, and kidney disease, with between 10 and 50% of ...
Susan T Arthur, Joshua M Noone, Bryce A Van Doren, Debosoree Roy, Christopher M Blanchette   +4 more
doaj   +1 more source

Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study

Journal of Cachexia, Sarcopenia and Muscle, 2021
Backgrounds Hand grip strength (HGS) is one of diagnose criteria factors of sarcopenia and is associated with the survival of patients with cancer. However, few studies have addressed the association of HGS and 1 year mortality of patients with cancer ...
Mengmeng Song, Qi Zhang, Meng Tang, Xi Zhang, Guotian Ruan, Xiaowei Zhang, Kangping Zhang, Yizhong Ge, Ming Yang, Qinqin Li, Xiangrui Li, Xiaoyue Liu, Wei Li, Minghua Cong, Kunhua Wang, Chunhua Song, Hanping Shi   +16 more
doaj   +1 more source